Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN).
NLMSF
SPAEN
leiomyosarcoma
research
treatment
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
20 Feb 2021
20 Feb 2021
Historique:
received:
29
01
2021
revised:
11
02
2021
accepted:
15
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
7
3
2021
Statut:
epublish
Résumé
As leiomyosarcoma patients are challenged by the development of metastatic disease, effective systemic therapies are the cornerstone of outcome. However, the overall activity of the currently available conventional systemic treatments and the prognosis of patients with advanced or metastatic disease are still poor, making the treatment of this patient group challenging. Therefore, in a joint effort together with patient networks and organizations, namely Sarcoma Patients EuroNet (SPAEN), the international network of sarcoma patients organizations, and the National LeioMyoSarcoma Foundation (NLMSF) in the United States, we aim to summarize state-of-the-art treatments for leiomyosarcoma patients in order to identify knowledge gaps and current unmet needs, thereby guiding the community to design innovative clinical trials and basic research and close these research gaps. This position paper arose from a leiomyosarcoma research meeting in October 2020 hosted by the NLMSF and SPAEN.
Identifiants
pubmed: 33672607
pii: cancers13040886
doi: 10.3390/cancers13040886
pmc: PMC7924026
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Lancet Oncol. 2017 Jun;18(6):812-822
pubmed: 28499583
Intractable Rare Dis Res. 2013 Nov;2(4):127-9
pubmed: 25343116
Ann Oncol. 2018 Feb 1;29(2):459-465
pubmed: 29069276
Lancet Oncol. 2018 Mar;19(3):416-426
pubmed: 29370992
Semin Cancer Biol. 2020 Apr;61:56-70
pubmed: 31722230
Clin Cancer Res. 2020 Feb 15;26(4):855-861
pubmed: 31796515
Clin Oncol (R Coll Radiol). 2013 Jun;25(6):343-5
pubmed: 23507441
J Clin Oncol. 2016 Mar 10;34(8):786-93
pubmed: 26371143
Immunol Rev. 2019 Jul;290(1):6-23
pubmed: 31355494
J Clin Oncol. 2009 Sep 1;27(25):4188-96
pubmed: 19652065
Eur J Cancer. 2010 Jan;46(1):72-83
pubmed: 19853437
JAMA. 2020 Apr 7;323(13):1266-1276
pubmed: 32259228
Lancet Oncol. 2015 Apr;16(4):457-64
pubmed: 25795402
Lancet Oncol. 2017 Nov;18(11):1493-1501
pubmed: 28988646
Lancet Oncol. 2019 Jun;20(6):837-848
pubmed: 31078463
Gynecol Oncol. 2011 Dec;123(3):553-6
pubmed: 21917307
Ann Oncol. 2010 Sep;21(9):1915-1921
pubmed: 20167595
JAMA Oncol. 2018 Jan 1;4(1):93-97
pubmed: 28662235
Biol Reprod. 2019 Dec 24;101(6):1115-1123
pubmed: 30184111
Clin Cancer Res. 2013 Mar 1;19(5):1190-6
pubmed: 23329812
Gynecol Oncol. 2016 Jul;142(1):89-94
pubmed: 27012429
Clin Cancer Res. 2019 Aug 15;25(16):5122-5134
pubmed: 31113844
Eur J Cancer. 2008 Apr;44(6):808-18
pubmed: 18378136
Nat Rev Genet. 2015 Jul;16(7):373-4
pubmed: 26077369
Cancer. 2013 Apr 15;119(8):1555-61
pubmed: 23335221
Genom Data. 2015 Sep 1;5:366-367
pubmed: 26240788
J Hematol Oncol. 2020 May 19;13(1):55
pubmed: 32430039
JAMA Oncol. 2020 Feb 1;6(2):e193332
pubmed: 31556911
Gynecol Oncol. 2017 Sep;146(3):531-537
pubmed: 28651804
Nature. 2020 Jan;577(7791):556-560
pubmed: 31942077
Gynecol Oncol. 2008 Jun;109(3):329-34
pubmed: 18534250
Arch Gynecol Obstet. 2016 Oct;294(4):825-31
pubmed: 27105972
Gynecol Oncol. 2017 Apr;145(1):208-216
pubmed: 28209496
Future Oncol. 2014 Jun;10(8 Suppl):s19-27
pubmed: 25048045
Pharmacol Res. 2019 Apr;142:169-175
pubmed: 30807865
J Transl Med. 2016 Mar 08;14:67
pubmed: 26952093
Curr Opin Obstet Gynecol. 2018 Feb;30(1):96-98
pubmed: 29251679
Nat Med. 2010 Jul;16(7):781-7
pubmed: 20581836
Cell. 2017 Nov 2;171(4):950-965.e28
pubmed: 29100075
J Clin Oncol. 2011 Jun 20;29(18):2528-33
pubmed: 21606430
Cancer. 2017 Sep 1;123(17):3291-3304
pubmed: 28463396
Br J Cancer. 1989 Sep;60(3):437-40
pubmed: 2789954
Oncologist. 2019 Jun;24(6):857-863
pubmed: 30126857
Exp Mol Pathol. 2017 Feb;102(1):156-161
pubmed: 28093192
Cancer. 2017 Sep 1;123(17):3285-3290
pubmed: 28440953
Ann Surg Oncol. 2013 Jun;20(6):1851-7
pubmed: 23354568
Cancer. 2007 May 1;109(9):1863-9
pubmed: 17385194
Mol Cancer Res. 2019 Mar;17(3):676-685
pubmed: 30518629
AJR Am J Roentgenol. 2018 May;210(5):1172-1177
pubmed: 29547053
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv51-iv67
pubmed: 29846498
Lancet Oncol. 2020 Oct;21(10):1366-1377
pubmed: 32941794
Mol Cancer Ther. 2019 Jun;18(6):1168-1178
pubmed: 30962320
JCO Precis Oncol. 2019;2019:
pubmed: 30793095
Oncogene. 2010 Feb 11;29(6):845-54
pubmed: 19901961
Lancet. 2012 May 19;379(9829):1879-86
pubmed: 22595799
JCO Precis Oncol. 2019;3:
pubmed: 32232185
Sarcoma. 2015;2015:412068
pubmed: 27057136
Clin Sarcoma Res. 2015 May 16;5:13
pubmed: 25987978
Am J Pathol. 2004 Jan;164(1):325-36
pubmed: 14695345
Cancer. 2019 Aug 1;125(15):2610-2620
pubmed: 31173362
Mol Cancer. 2017 Apr 28;16(1):86
pubmed: 28454547
Ann Surg. 2007 Jun;245(6):952-8
pubmed: 17522521
Ann Oncol. 2010 Jun;21(6):1361-1365
pubmed: 19880438
Cancer. 2020 Jun 1;126(11):2637-2647
pubmed: 32129883
J Surg Oncol. 2017 Sep;116(3):313-319
pubmed: 28557016
Lancet. 2016 Apr 16;387(10028):1629-37
pubmed: 26874885
Ann Oncol. 2017 Nov 1;28(11):2852-2859
pubmed: 29117335
J Clin Oncol. 2018 Sep 11;:JCO2018788620
pubmed: 30204536
J Clin Oncol. 2007 Jul 1;25(19):2755-63
pubmed: 17602081
Mol Cancer Res. 2020 Sep;18(9):1302-1314
pubmed: 32518213
Crit Rev Oncol Hematol. 2008 Feb;65(2):129-42
pubmed: 17706430
Gynecol Oncol. 2009 Mar;112(3):563-7
pubmed: 19135708
Cancer. 2018 Dec 1;124(23):4495-4503
pubmed: 30317543
Clin Cancer Res. 2018 Jun 1;24(11):2688-2699
pubmed: 29463554
Cancer. 2014 Mar 1;120(5):738-43
pubmed: 24222211
Eur Radiol. 2017 Jul;27(7):2903-2915
pubmed: 27921159
Gynecol Oncol. 2008 Jun;109(3):323-8
pubmed: 18394689
Ann Oncol. 2013 Jun;24(6):1703-9
pubmed: 23385197
Lancet Oncol. 2017 Oct;18(10):1397-1410
pubmed: 28882536
Nat Commun. 2018 Jan 10;9(1):144
pubmed: 29321523
Mol Imaging Biol. 2019 Dec;21(6):1157-1164
pubmed: 30850967
Cell Rep. 2017 Jan 24;18(4):991-1004
pubmed: 28122247
Oncologist. 2012;17(9):1213-20
pubmed: 22907974
Lancet Oncol. 2014 Apr;15(4):415-23
pubmed: 24618336